Immune recovery uveitis in patients with AIDS and cytomegalovirus retinitis after highly active antiretroviral therapy

American Journal of Ophthalmology

Volumn 129, Issue 5, 2000, Pages 634-639

  Nguyen, Quan Dong ^a   Kempen, John H ^a   Bolton, Stephen G ^a   Dunn, James P ^a   Jabs, Douglas A ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; CD4 ANTIGEN; CIDOFOVIR; PROTEINASE INHIBITOR; RNA DIRECTED DNA POLYMERASE INHIBITOR;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; ARTICLE; CYTOMEGALOVIRUS INFECTION; FEMALE; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; IMMUNE RESPONSE; INCIDENCE; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; NEOVASCULARIZATION (PATHOLOGY); OPTIC DISK; PRIORITY JOURNAL; RETINA MACULA CYSTOID EDEMA; RETINITIS; RETROSPECTIVE STUDY; T LYMPHOCYTE; UVEITIS; VISUAL IMPAIRMENT;

ADOLESCENT; ADULT; AIDS-RELATED OPPORTUNISTIC INFECTIONS; CD4 LYMPHOCYTE COUNT; CD4-POSITIVE T-LYMPHOCYTES; CHILD; CYTOMEGALOVIRUS RETINITIS; DRUG THERAPY, COMBINATION; FEMALE; HIV PROTEASE INHIBITORS; HIV-1 REVERSE TRANSCRIPTASE; HUMANS; MALE; MIDDLE AGED; REVERSE TRANSCRIPTASE INHIBITORS; UVEITIS, POSTERIOR; VITREOUS BODY;

EID: 0034032786     PISSN: 00029394     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9394(00)00356-1     Document Type: Article

References (26)

1. Jabs D.A. Ocular manifestations of HIV infection. Trans Am Ophthalmol Soc. 93:1995;623-683.
2. Moore R.D., Chaisson R.E. Natural history of opportunistic disease in an HIV-infected urban clinical cohort. Ann Intern Med. 124:1996;633-642.
3. Jabs D.A., Bartlett J.G. AIDS and ophthalmology a period of transition . Am J Ophthalmol. 124:1997;227-233.
4. Gallant J.E., Moore R.D., Richman D.D., Keruly J., Chaisson R.E. Incidence and natural history of cytomegalovirus disease in patients with advanced human immunodeficiency virus disease treated with zidovudine the Zidovudine Epidemiology Group . J Infect Dis. 166:1992;1223-1227.
5. Pertel P., Hirschtick R., Phair J., Chmiel J., Poggensee L., Murphy R. Risk of developing cytomegalovirus retinitis in persons infected with the human immunodeficiency virus. J Acquir Immune Defic Syndr. 5:1992;1069-1074.
6. Hoover D.R., Peng Y., Saah A., et al. Occurrence of cytomegalovirus retinitis after human immunodeficiency virus immunosuppression. Arch Ophthalmol. 114:1996;821-827.
7. Gulick R.M., Mellors J.W., Havlir D., et al. Treatment with indinavir, zidovudine, and lamivudine in adults with human immunodeficiency virus infection and prior antiretroviral therapy. N Engl J Med. 337:1997;734-739.
8. Hammer S.M., Squires K.E., Hughes M.D., et al. A controlled trial of two nucleoside analogues plus indinavir in persons with human immunodeficiency virus infection and CD cell counts of 200 per cubic millimeter or less AIDS Clinical Trials Group 320 Study Team . N Engl J Med. 337:1997;725-733.
9. Palella F.J., Delaney K.M., Moorman A.C., et al. Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection HIV Outpatient Study Investigators . N Engl J Med. 338:1998;853-860.
10. Whitcup S.M., Fortin E., Nussenblatt R.B., Polis M.A., Muccioli C., Belfort R. Jr. Therapeutic effect of combination antiretroviral therapy on cytomegalovirus retinitis. JAMA. 277:1997;1519-1520.
11. Jabs D.A., Bolton S.G., Dunn J.P., Palestine A.G. Discontinuing anticytomegalovirus therapy in patients with immune reconstitution after combination antiretroviral therapy. Am J Ophthalmol. 126:1998;817-822.
12. Macdonald J.C., Torriani F.J., Morse L.S., Karavellas M.P., Reed J.B., Freeman W.R. Lack of reactivation of cytomegalovirus (CMV) retinitis after stopping CMV maintenance therapy in AIDS patients with sustained elevations in CD4 T cells in response to highly active antiretroviral therapy. J Infect Dis. 177:1998;1182-1187.
13. Tural C., Romeu J., Sirera G., et al. Long-lasting remission of cytomegalovirus retinitis without maintenance therapy in human immunodeficiency virus-infected patients. J Infect Dis. 177:1998;1080-1083.
14. Karavellas M.P., Lowder C.Y., Macdonald C., Avila C.P. Jr, Freeman W.R. Immune recovery vitritis associated with inactive cytomegalovirus retinitis a new syndrome . Arch Ophthalmol. 116:1998;169-175.
15. Zegans M.E., Walton R.C., Holland G.N., O'Donnell J.J., Jacobson M.A., Margolis T.P. Transient vitreous inflammatory reactions associated with combination antiretroviral therapy in patients with AIDS and cytomegalovirus retinitis. Am J Ophthalmol. 125:1998;292-300.
16. Karavellas M.P., Plummer D.J., Macdonald J.C., et al. Incidence of immune recovery vitritis in cytomegalovirus retinitis patients following institution of successful highly active antiretroviral therapy. J Infect Dis. 179:1999;697-700.
17. 1993 revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults. MMWR Morb Mortal Wkly Rep. 41:1992;1-20.
18. Foscarnet-Ganciclovir Cytomegalovirus Retinitis Trial, 4: visual outcomes. Studies of Ocular Complications of AIDS Research Group in collaboration with the AIDS Clinical Trials Group. Ophthalmology 1994;101:1250-1261.
19. Hogan M., Kimura S., Thygeson P. Signs and symptoms of uveitis, I anterior uveitis . Am J Ophthalmol. 47:1959;155-170.
20. Kimura S., Thygeson P., Hogan M. Signs and symptoms of uveitis, II classification of the posterior manifestations of uveitis . Am J Ophthalmol. 47:1959;171-176.
21. Kaplan E.E., Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc. 53:1958;457-481.
22. Efron B., Tibshirani R. Boostrap methods for standard errors, confidence intervals, and other measures of statistical accuracy. Stat Sci. 1:1986;54-77.
23. Nussenblatt R.B., Lane H.C. Human immunodeficiency virus disease changing patterns of intraocular inflammation . Am J Ophthalmol. 125:1998;374-382.
24. Phillips P, Zala C, Rouleau D, Montaner JSG. Mycobacterial lymphadenitis: can highly active antiretroviral therapy unmask subclinical infection (abstract)? In: Fourth Conference on Retroviruses and Opportunistic Infections: program and abstracts (Washington, DC). Alexandria: Infectious Diseases Society of America, 1996:129.
25. Musch D.C., Martin D.F., Gordon J.F., Davis M.D., Kupperman B.D. Treatment of cytomegalovirus retinitis with a sustained-release ganciclovir implant the Ganciclovir Implant Study Group . N Engl J Med. 337:1997;83-90.
26. Martin D.F., Kupperman B.D., Wolitz R.A., et al. Oral ganciclovir for patients with cytomegalovirus retinitis treated with a ganciclovir implant. N Engl J Med. 340:1999;1063-1070.